The robust growth in the pharmaceutical markets of
emerging world economies has outpaced the overall growth of the global
pharmaceutical market. The emerging markets are being driven by rapidly
growing economies of these countries, increasing per capita income,
increasing prevalence of lifestyle diseases due to rapid urbanization,
and low-cost factors. Mainly due to strong performance in the emerging
pharmaceutical markets, the global pharmaceutical market is expected to
reach US$ 1,020 Billion by the end of 2012. This research study provides
extensive and coherent information about pharmaceutical markets in
emerging countries. It also gives a detailed statistical and analytical
review on the demographics, macroeconomic indicators, disease profile,
key drivers and restraints of the emerging pharmaceutical markets.
report covers all the key aspects of the various emerging
pharmaceutical markets and has broadly outlined the factors that are
affecting the industry. The report also provides current and predicted
future performance of the pharmaceutical market in different regions of
the world. Key countries of each region have been covered and the status
of pharmaceutical industry has been provided. Moreover, the report
provides information regarding therapeutic segments and key companies.
Besides, detail information regarding generics, patented drugs and
prescription drugs have been included for all the countries. It provides
segment level analysis of the industry along with emerging trends on
intellectual property, market opportunities, research collaborations,
partnership activities, and guidelines for establishing new ventures.
The research will help consultants, industry analysts, and vendors to
get in-depth knowledge of the current, past, and future performance of
the emerging pharmaceutical markets.